NEXO THERAPEUTICS, INC.
Profile
Company Names
NEXO THERAPEUTICS, INC.
Addresses
11757 W. KEN CARYL AVENUE, SUITE F, 520, LITTLETON, CO 80127-3719
Phone Numbers
303-868-6790
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
2022
State Incorporated:
DELAWARE
Total Amount Raised:
$60,000,000.00
Number of Funding Rounds:
1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2022-11-15
$60,000,000.00
$60,000,000.00
$0.00
Equity, Debt
People
First Name
Middle Name
Last Name
Titles
Related Companies
ALI
BEHBAHANI
DIRECTOR
ROTATION MEDICAL INC
| DENALI MEDICAL II, INC.
| MINERVA SURGICAL INC
| PROSPEX MEDICAL III, INC.
| OCULEVE, INC.
| CVRX INC
| IVANTIS, INC.
| ADAPTIMMUNE LTD
| CARDIONOMIC, INC.
| CVRX, INC.
| SOLACE THERAPEUTICS INC
| CRISPR THERAPEUTICS AG
| OYSTER POINT PHARMA, INC.
| GENOCEA BIOSCIENCES, INC.
| BLACK DIAMOND THERAPEUTICS, INC.
| SPYGLASS OPHTHALMICS, INC.
| ARCELLX, INC.
| NKARTA, INC.
| NEA BH SPV, L.P.
| NEA BH SPV II, L.P.
| MONTE ROSA THERAPEUTICS, INC.
| 858 THERAPEUTICS, INC.
| NEW ENTERPRISE ASSOCIATES 18, L.P.
| NEA 18 VENTURE GROWTH EQUITY, L.P.
| FIRSTLIGHT BIO, INC.
| NEXO THERAPEUTICS, INC.
| LAUNCHPAD THERAPEUTICS, INC.
| NEA SH SPV, L.P.
| SPYGLASSPHARMA, INC.
| NEA RP SPV, L.P.
| NEA CH SPV, L.P.
| NEA TS 2024 SPV, L.P.
| NEA SECONDARY OPPORTUNITY FUND, L.P.
| TUNE THERAPEUTICS, INC.
MICHAEL
KIM
EXECUTIVE OFFICER
CAPELLA PHOTONICS INC
| INSYNC SOFTWARE INC
| LIVE GAMER INC
| CENDANA CO-INVESTMENT FUND, L.P.
| CENDANA CAPITAL, L.P.
| FORERUNNER JPGT OPPORTUNITIES FUND, LLC
| CENDANA INVESTMENTS, LP
| ELAH CAPITAL GROUP ONSHORE FEEDER LP
| ELAH CAPITAL GROUP MASTER FUND LP
| OUTLIER AI, INC.
| CENDANA KENDALL, LP
| CENDANA CAPITAL III, L.P.
| CENDANA INVESTMENTS II, LP
| CENDANA BLACKBIRD, L.P.
| CENDANA LONGHORNS, L.P.
| CENDANA CAPITAL IV, L.P.
| CENDANA CAPITAL IV (INTERNATIONAL), L.P.
| ADGORITHMICS, INC.
| CENDANA CAPITAL IV, L.P. - CLASS #1
| CENDANA CAPITAL IV, L.P. - CLASS #2
| CENDANA CAPITAL IV, L.P. - CLASS #3
| ARKADIA SYSTEMATIC EQUITY FUND
| ACRES MORTGAGE FUND LTD.
| A+Q ALTERNATIVE YIELD FUND LLC
| A+Q ALTERNATIVE YIELD FUND LTD
| INDY HEALTH HOLDINGS LLC
| VALTED SEQ, INC.
| PLENARYAI, INC.
| OSARO, INC.
| GABMAR VITAE LLC
| A+Q CARMEN DIVERSIFIED ALPHA STRATEGY FUND (DELAWARE) LLC
| ZEROEYES, INC.
| PAE LTD
| A+Q FOOD DELIVERY MASTER LTD
| CENDANA KEARNEY, LP
| NEXO THERAPEUTICS, INC.
| CORNAMI, INC.
| CENDANA INTERNATIONAL II, L.P.
| CENDANA INVESTMENTS III, LP
| CENDANA CAPITAL V, L.P.
| KHC PARTNERS FUND LP
| NINETEEN77 WORKING CAPITAL FINANCE OPPORTUNISTIC FUND LLC
| NINETEEN77 WORKING CAPITAL FINANCE OPPORTUNISTIC FUND LTD
| QOLAB, INC.
| AEGERI CAPITAL FUND LP
| AEGERI CAPITAL OFFSHORE FUND LTD.
| FIRST RESONANCE, INC.
| CENDANA SANDSTORM, L.P.
| CENDANA CAPITAL VI, L.P.
| EVERSTAR INC.
| TSBOT LIQUIDITY FUND, LP
| THIRD PRIME ALPHA FUND IV, LP
| KHC PARTNERS FUND II LP
| KHC PARTNERS OFFSHORE FUND II LP
| CENDANA KEARNEY II, LP - CLASS #2
| CENDANA KEARNEY II, LP - CLASS #1
| CENDANA KEARNEY II, LP - CLASS #3
ANDREW
PHILLIPS
EXECUTIVE OFFICER, DIRECTOR
CARLO
RIZZUTO
DIRECTOR
VENATORX PHARMACEUTICALS, INC.
| QUENTIS THERAPEUTICS, INC.
| PANDION THERAPEUTICS, INC.
| PANDION THERAPEUTICS HOLDCO LLC
| GRAPHITE BIO, INC.
| CENTURY THERAPEUTICS, INC.
| 858 THERAPEUTICS, INC.
| JNANA THERAPEUTICS INC.
| NEXO THERAPEUTICS, INC.
| VERSANT VOYAGEURS III, L.P.
| VERSANT VOYAGEURS III (CANADA), L.P.
| VERSANT VANTAGE III, L.P.
| VERSANT VANTAGE III (CANADA), L.P.
| VERSANT VENTURE CAPITAL IX, L.P.
| VERSANT VENTURE CAPITAL IX (CANADA), L.P.
| PEP2TANGO THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

